We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Novel Surgical Technique Enables Scarless Removal of Large Polyps

By HospiMedica International staff writers
Posted on 05 Sep 2011
A new operating platform for Trans-Anal Minimally Invasive Surgery (TAMIS) allows surgeons to excise large rectal polyps and tumor masses that cannot be completely removed during a routine colonoscopy.

During a TAMIS procedure, thin surgical instruments are placed through a soft but stable surgical platform--similar to a single incision laparoscopy (SIL) port--that rests inside the anus. More...
The platform permits full visualization of the rectal growth, allowing surgeons to precisely access and excise the abnormality. The intact growth can then be removed through the anus, allowing pathologists to more accurately evaluate and diagnose its thickness. The tissue defect where the growth was removed is then closed with internal stitches; there are no permanent scars on the abdomen or around the anus.

TAMIS, which was pioneered at Florida Hospital (Winter Park, USA) by Sam Atallah, MD, will likely serve as the future platform for rectal natural orifice translumenal endoscopic surgery (NOTES), and may also have implications for treating patients with familial adenomatous polyposis, Gardner's syndrome, and Lynch syndrome, inherited genetic conditions that result in the mass growth of polyps.

“With the use of this new surgical platform, we can now offer patients an innovative, less invasive procedure to remove advanced polyps with significantly less pain and scarring compared to the standard surgical procedure,” said Elisabeth McLemore, MD, a colorectal surgeon at the University of California, San Diego (UCSD; USA), and the third surgeon in the world to perform the procedure. “Instead of a major abdominal operation with removal and reconstruction of the colon and rectum, we can remove the growth by operating through an existing natural body opening.”

“What we are seeing here is an evolution of natural orifice translumenal endoscopic surgery, the ability to perform complex operations through natural body openings,” added Professor Mark Talamini, MD, chairman of surgery and codirector of the Center for the Future of Surgery at the UCSD Health System. “Four years ago we predicted that NOTES would evolve to treat early forms of cancers, and that is what we are seeing now at UC San Diego.”

Related Links:
Florida Hospital
University of California, San Diego


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.